Michal Mokry1, Sabine Middendorp1, Caroline L Wiegerinck1, Merlijn Witte2, Hans Teunissen2, Claartje A Meddens1, Edwin Cuppen3, Hans Clevers4, Edward E S Nieuwenhuis5. 1. Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands; Hubrecht Institute for Stem Cell Research, Utrecht, The Netherlands. 3. Hubrecht Institute for Stem Cell Research, Utrecht, The Netherlands; Department of Medical Genetics, Medical Center Utrecht, Utrecht, The Netherlands. 4. Hubrecht Institute for Stem Cell Research, Utrecht, The Netherlands. 5. Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: E.E.S.Nieuwenhuis@umcutrecht.nl.
Abstract
BACKGROUND & AIMS: The contribution of genetic factors to the pathogenesis of inflammatory bowel disease (IBD) has been established by twin, targeted-sequencing, and genome-wide association studies. These studies identified many risk loci, and research is underway to identify causal variants. These studies have focused mainly on protein-coding genes. We investigated other functional elements in the human genome, such as regulatory regions. METHODS: Using acetylated histone 3 lysine 27 chromatin immunoprecipitation and sequencing, we identified tens of thousands of potential regulatory regions that are active in intestinal epithelium (primary intestinal crypts and cultured organoids) isolated from resected material and from biopsies collected during ileo-colonoscopies and immune cells (monocytes, macrophages, CD34(+), CD4(+), and CD8(+)). We correlated these regions with susceptibility loci for IBD. RESULTS: We have generated acetylated histone 3 lysine 27 profiles from primary intestinal epithelium and cultured organoids, which we have made publically available. We found that 45 of 163 single nucleotide polymorphisms (SNPs) associated with IBD overlap specifically with active regulatory elements. In addition, by taking strong linkage disequilibrium into account, another 47 IBD-associated SNPs colocalized with active regulatory elements through other SNPs in their vicinity. Altogether, 92 of 163 IBD-associated SNPs correlated with distinct active regulatory elements-a frequency 2.5- to 3.5-fold greater than that expected from random sampling. The variations in these SNPs often create or disrupt known binding motifs; they might affect the binding of transcriptional regulators to alter expression of regulated genes. CONCLUSIONS: In addition to variants in protein coding genes, variants in noncoding DNA regulatory regions that are active in intestinal epithelium and immune cells are potentially involved in the pathogenesis of IBD.
BACKGROUND & AIMS: The contribution of genetic factors to the pathogenesis of inflammatory bowel disease (IBD) has been established by twin, targeted-sequencing, and genome-wide association studies. These studies identified many risk loci, and research is underway to identify causal variants. These studies have focused mainly on protein-coding genes. We investigated other functional elements in the human genome, such as regulatory regions. METHODS: Using acetylated histone 3 lysine 27 chromatin immunoprecipitation and sequencing, we identified tens of thousands of potential regulatory regions that are active in intestinal epithelium (primary intestinal crypts and cultured organoids) isolated from resected material and from biopsies collected during ileo-colonoscopies and immune cells (monocytes, macrophages, CD34(+), CD4(+), and CD8(+)). We correlated these regions with susceptibility loci for IBD. RESULTS: We have generated acetylated histone 3 lysine 27 profiles from primary intestinal epithelium and cultured organoids, which we have made publically available. We found that 45 of 163 single nucleotide polymorphisms (SNPs) associated with IBD overlap specifically with active regulatory elements. In addition, by taking strong linkage disequilibrium into account, another 47 IBD-associated SNPs colocalized with active regulatory elements through other SNPs in their vicinity. Altogether, 92 of 163 IBD-associated SNPs correlated with distinct active regulatory elements-a frequency 2.5- to 3.5-fold greater than that expected from random sampling. The variations in these SNPs often create or disrupt known binding motifs; they might affect the binding of transcriptional regulators to alter expression of regulated genes. CONCLUSIONS: In addition to variants in protein coding genes, variants in noncoding DNA regulatory regions that are active in intestinal epithelium and immune cells are potentially involved in the pathogenesis of IBD.
Authors: Ta-Chiang Liu; Justin T Kern; Kelli L VanDussen; Shanshan Xiong; Gerard E Kaiko; Craig B Wilen; Michael W Rajala; Roberta Caruso; Michael J Holtzman; Feng Gao; Dermot Pb McGovern; Gabriel Nunez; Richard D Head; Thaddeus S Stappenbeck Journal: J Clin Invest Date: 2018-10-15 Impact factor: 14.808
Authors: Elizabeth M McDonough; Caitlyn W Barrett; Bobak Parang; Mukul K Mittal; J Joshua Smith; Amber M Bradley; Yash A Choksi; Lori A Coburn; Sarah P Short; Joshua J Thompson; Baolin Zhang; Shenika V Poindexter; Melissa A Fischer; Xi Chen; Jiang Li; Frank L Revetta; Rishi Naik; M Kay Washington; Michael J Rosen; Scott W Hiebert; Keith T Wilson; Christopher S Williams Journal: JCI Insight Date: 2017-08-17
Authors: Sanjay Chahar; Vishal Gandhi; Shiyan Yu; Kinjal Desai; Richard Cowper-Sal-lari; Yona Kim; Ansu O Perekatt; Namit Kumar; Joshua K Thackray; Anthony Musolf; Nikhil Kumar; A Hoffman; Douglas Londono; Berta N Vazquez; Lourdes Serrano; Hyunjin Shin; Mathieu Lupien; Nan Gao; Michael P Verzi Journal: Mol Cell Biol Date: 2014-06-30 Impact factor: 4.272